AT1 FY21 - General Discussion + FA, page-742

I agree with you it is underperforming the market
However, it's all about personal choices. It has its run to 450 before the FY report, there's a chance to sell and make a profit
If you enter now, there's very limited downsides and lots of upsides.
And when you look at companies like RMD, NAN. It takes time for medical companies to take off
It's not even listed for a year... EMV share price has done nothing for about a year after listed, look where it is now
AT1 may not be like that but it's definitely gonna grow
I think it's all about investing time frames and expectation for returns